Join the club for FREE to access the whole archive and other member benefits.

Oklahoma Medical Research Foundation (OMRF)

Biomedical research institute developing effective treatments for different human diseases.

OMRF was founded as a non-profit organization in 1946 with the mission of conducting basic biomedical research to help people live longer, healthier lives. Our scientists are dedicated to understanding and curing human disease and focus on such critical research areas as lupus, multiple sclerosis, heart disease, cancer and Alzheimer’s disease.

From OMRF’s inception, our scientists have focused on making laboratory breakthroughs that have a tangible impact on human health. Researchers at OMRF made discoveries that proved crucial to the creation of the protease inhibition cocktails that have added decades to the lives of patients suffering from HIV/AIDS. OMRF discoveries have given birth to a drug to treat children suffering from a life-threatening deficiency of protein C. Work in our labs also led to the creation of Soliris, the first and only treatment for a rare blood disorder known as PNH. A drug with OMRF roots became the first drug licensed under the European Union’s centralized procedure. And our researchers have created diagnostic and disease management tests for lupus and rheumatoid arthritis that are used in hospitals and clinics around the world.

Visit website: https://omrf.org/

 OMRFOK

 omrf---the-oklahoma-medical-research-foundation

 OMRF

 OMRFOK

Details last updated 12-Dec-2019

People at Oklahoma Medical Research Foundation (OMRF)

Ying Ann Chiao

Assistant Member at Oklahoma Medical Research Foundation.

Benjamin Miller

Researcher in the Aging and Metabolism Research Program at OMRF.

Oklahoma Medical Research Foundation (OMRF) News

NIH awarded OMRF $3 million to study anti-aging abilities of a diabetic drug

NIH awarded OMRF $3 million to study anti-aging abilities of a diabetic drug

Oklahoma Medical Research Foundation (OMRF) - 13-Jul-2022

Investigation of ability of metformin, a diabetic drug to slow the process of aging

It's time for considering drug-exercise interactions

It's time for considering drug-exercise interactions

New York Times - 19-Jun-2019

Interesting - metformin plus exercise did not have an additive effect